Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How we collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

Genetic Evidence for Soluble VEGFR2 as a Protective Factor Against Macular Pucker

Submitted by Frida Mäkelä on Mon, 12/16/2024 - 12:16
  • Read more about Genetic Evidence for Soluble VEGFR2 as a Protective Factor Against Macular Pucker

Expanding the genetic landscape of endometriosis: Integrative -omics analyses uncover key pathways from a multi-ancestry study of over 900,000 women

Submitted by Frida Mäkelä on Mon, 12/16/2024 - 12:12
  • Read more about Expanding the genetic landscape of endometriosis: Integrative -omics analyses uncover key pathways from a multi-ancestry study of over 900,000 women

Extensive antagonistic variants across human genome

Submitted by Frida Mäkelä on Mon, 12/16/2024 - 12:10
  • Read more about Extensive antagonistic variants across human genome

Blood methylation biomarkers are associated with diabetic kidney disease progression in type 1 diabetes

Submitted by Frida Mäkelä on Mon, 12/16/2024 - 12:06
  • Read more about Blood methylation biomarkers are associated with diabetic kidney disease progression in type 1 diabetes

Bayesian Mendelian Randomization Analysis for Latent Exposures Leveraging GWAS Summary Statistics for Traits Co-Regulated by the Exposures

Submitted by Frida Mäkelä on Mon, 12/16/2024 - 12:04
  • Read more about Bayesian Mendelian Randomization Analysis for Latent Exposures Leveraging GWAS Summary Statistics for Traits Co-Regulated by the Exposures

Sparse matrix factorization robust to sample sharing across GWASs reveals interpretable genetic components

Submitted by Frida Mäkelä on Mon, 12/16/2024 - 12:01
  • Read more about Sparse matrix factorization robust to sample sharing across GWASs reveals interpretable genetic components

The genetic basis of dermatophytosis skin infection susceptibility

Submitted by Frida Mäkelä on Mon, 12/16/2024 - 11:58
  • Read more about The genetic basis of dermatophytosis skin infection susceptibility

Relationships between 25-Hydroxyvitamin D and Alpha-synucleinopathies: A Mendelian Randomization Study

Submitted by Frida Mäkelä on Mon, 12/16/2024 - 11:55
  • Read more about Relationships between 25-Hydroxyvitamin D and Alpha-synucleinopathies: A Mendelian Randomization Study

Molecular convergence of risk variants for congenital heart defects leveraging a regulatory map of the human fetal heart

Submitted by Frida Mäkelä on Mon, 12/16/2024 - 11:47
  • Read more about Molecular convergence of risk variants for congenital heart defects leveraging a regulatory map of the human fetal heart

Central role of glycosylation processes in human genetic susceptibility to SARS-CoV-2 infections with Omicron variants

Submitted by Frida Mäkelä on Mon, 12/16/2024 - 11:38
  • Read more about Central role of glycosylation processes in human genetic susceptibility to SARS-CoV-2 infections with Omicron variants

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 195
  • Page 196
  • Page 197
  • Page 198
  • Current page 199
  • Page 200
  • Page 201
  • Page 202
  • Page 203
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement